(Q37045107)

17 August 2017

Hospitalization due to adverse drug reactions and drug interactions before and after HAART. (English)

1 reference

17 August 2017

1 reference

M M Foisy

1

1 reference

17 August 2017

K Gough

2

1 reference

17 August 2017

C M Quan

3

1 reference

17 August 2017

K Harris

4

1 reference

17 August 2017

D Ibanez

5

1 reference

17 August 2017

A Phillips

6

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Canadian Journal of Infectious Diseases & Medical Microbiology

17 August 2017

1 reference

17 August 2017

11

1 reference

17 August 2017

4

1 reference

17 August 2017

193-201

1 reference

Creative Commons Attribution 4.0 International

17 August 2017

start time

1 January 2000

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Significant interactions with new antiretrovirals and psychotropic drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

Drug-related hospital admissions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

Drug hypersensitivity reactions and human immunodeficiency virus disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

Acute interstitial nephritis secondary to the administration of indinavir

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

Indinavir and interstitial nephritis

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

Management of drug interactions in patients with HIV.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

Urinary stones in HIV-1-positive patients treated with indinavir

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

New antiretrovirals and new combinations.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

Acute hepatitis in HIV-infected patients during ritonavir treatment

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094765

Vascular and lipid syndromes in selected HIV-infected patients

20 October 2018

1 reference

12 December 2020

Allergic drug reactions: identification and management

1 reference

12 December 2020

Exacerbated Hyperglycemia Associated with Nelfinavir

1 reference

12 December 2020

1 reference

12 December 2020

Fatal case of 2',3'-dideoxyinosine-associated pancreatitis

1 reference

12 December 2020

Severe premature coronary artery disease with protease inhibitors

1 reference

12 December 2020

Drug-associated hospital admissions in older medical patients

1 reference

12 December 2020

Identifiers

DOI

10.1155/2000/123046

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

18159290

1 reference